LSC: OPCU Microbial Capacity Update – June 2026

Home | LSC: OPCU Microbial Capacity Update – June 2026

Explore FUJIFILM Biotechnologies’ process development capabilities that make reaching IND quickly a reality, while our experts work with you to create flexible approaches to BLA.

Watch now to hear how FUJIFILM Biotechnologies Microbial Center of Excellence in Billingham, UK:


  • Supports partners to optimize yields and accelerate process development to accomplish drug substance batch release within 11 months for therapies derived from a range of microbial hosts.
  • Creates robust processes for molecules that are difficult to express, purify, analyze, and conjugate/PEGylate in a range of microbial hosts.
  • Has the capacity and scale to manufacture a range of diverse microbial therapies.